Human Genome Epidemiology Literature Finder
Records 1 - 8 (of 8 Records) |
Query Trace: Myelofibrosis and TERT[original query] |
---|
Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common TERT Polymorphism rs2736100. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015 Oct . Krahling Tunde, Balassa Katalin, Kiss Katalin P, Bors Andras, Batai Arpad, Halm Gabriella, Egyed Miklos, Fekete Sandor, Remenyi Peter, Masszi Tamas, Tordai Attila, Andrikovics Hajnal |
Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms. Blood 2016 Jun . Hinds David A, Barnholt Kimberly E, Mesa Ruben A, Kiefer Amy K, Do Chuong B, Eriksson Nicholas, Mountain Joanna L, Francke Uta, Tung Joyce Y, Nguyen Huong Marie, Zhang Haiyu, Gojenola Linda, Zehnder James L, Gotlib Jas |
TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients. British journal of haematology 2016 Apr . Trifa Adrian P, B?nescu Claudia, Tevet Mihaela, Bojan Anca, Dima Delia, Urian Laura, Török-Vistai Tünde, Popov Viola M, Zdrenghea Mihnea, Petrov Ljubomir, Vasilache Anca, Murat Meilin, Georgescu Daniela, Popescu Mihaela, P?trinoiu Oana, Balea Marius, Costache Roxana, Cole? Elena, ?aguna Carmen, Berbec Nicoleta, Vl?d?reanu Ana-Maria, Mih?il? Romeo G, Bumbea Horia, Cucuianu Andrei, Popp Radu |
A TET2 rs3733609 C/T genotype is associated with predisposition to the myeloproliferative neoplasms harboring JAK2(V617F) and confers a proliferative potential on erythroid lineages. Oncotarget 2016 Jan . Shen Xiao-Hui, Sun Nan-Nan, Yin Ya-Fei, Liu Su-Fang, Liu Xiao-Liu, Peng Hong-Ling, Dai Chong-Wen, Xu Yun-Xiao, Deng Ming-Yang, Luo Yun-Ya, Zheng Wen-Li, Zhang Guang-S |
Germline variations at JAK2, TERT, HBS1L-MYB and MECOM and the risk of myeloproliferative neoplasms in Taiwanese population. Oncotarget 2017 Sep 8 (44): 76204-76213. Chiang Yi-Hao, Chang Yu-Cheng, Lin Huan-Chau, Huang Ling, Cheng Chun-Chia, Wang Wei-Ting, Cheng Hung-I, Su Nai-Wen, Chen Caleb Gon-Shen, Lin Johnson, Chang Yi-Fang, Chang Ming-Chih, Hsieh Ruey-Kuen, Chou Wen-Chien, Lim Ken-Hong, Kuo Yuan-Y |
MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients. American journal of hematology 2017 Oct . Trifa Adrian P, B?nescu Claudia, Bojan Anca S, Voina Cristian M, Popa ?tefana, Vi?an Simona, Ciubean Alina D, Tripon Florin, Dima Delia, Popov Viola M, Vesa ?tefan C, Andreescu Mihaela, Török-Vistai Tünde, Mih?il? Romeo G, Berbec Nicoleta, Macarie Ioan, Coli?? Andrei, Iordache Maria, C?tan? Alina C, Farca? Marius F, Tomuleasa Ciprian, Vasile Kinga, Truic? Cristina, Todinc? Adriana, Pop-Muntean Lavinia, Manolache Raluca, Bumbea Horia, Vl?d?reanu Ana-Maria, Gaman Mihaela, Ciufu Cristina M, Popp Radu |
TERT and JAK2 polymorphisms define genetic predisposition to myeloproliferative neoplasms in Japanese patients. International journal of hematology 2019 Sep . Matsuguma Masafumi, Yujiri Toshiaki, Yamamoto Kaoru, Kajimura Yasuko, Tokunaga Yoshihiro, Tanaka Mayumi, Tanaka Yoshinori, Nakamura Yukinori, Tanizawa Yuk |
JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome. Journal of cancer research and clinical oncology 2022 Oct . Kandu?a Zuzanna, Janowski Micha?, Wi?ckowska Barbara, Paczkowska Edyta, Lewandowski Krzyszt |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: